Nivolumab monotherapy or combination therapy with ipilimumab for lung cancer: a systemic review and meta-analysis

被引：0
|
作者：
Huihui Jiang
Aiqun Xu
Wanli Xia
Xingyuan Xia
Pulin Li
Binbin Zhang
Ke Zhu
Sijing Zhou
Ran Wang
机构：
[1] The First Affiliated Hospital of Anhui Medical University,Department of Respiratory and Critical Care Medicine
[2] Hefei Second People’s Hospital,Department of General Medicine
[3] The First Affiliated Hospital of Anhui Medical University,Department of Thoracic Surgery
[4] Hefei Third Clinical College of Anhui Medical University,undefined
[5] Hefei Prevention and Treatment Center for Occupational Diseases,undefined
来源：
Cancer Cell International | / 21卷
关键词：
Antitumor drugs; Ipilimumab; Lung cancer; Nivolumab; Immunotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Iguratimod combination therapy compared with methotrexate monotherapy for the treatment of rheumatoid arthritis: a systematic review and meta-analysis
    Sajan Shrestha
    Jing Zhao
    Changqing Yang
    Jinping Zhang
    Clinical Rheumatology, 2021, 40 : 4007 - 4017
  • [42] Iguratimod combination therapy compared with methotrexate monotherapy for the treatment of rheumatoid arthritis: a systematic review and meta-analysis
    Shrestha, Sajan
    Zhao, Jing
    Yang, Changqing
    Zhang, Jinping
    CLINICAL RHEUMATOLOGY, 2021, 40 (10) : 4007 - 4017
  • [43] Optimal dosing interval of intravenous Colistin monotherapy versus combination therapy: A systematic review and meta-analysis
    Ahmadpour, Forouzan
    Shaseb, Elnaz
    Izadpanah, Mandana
    Rakhshan, Amin
    Hematian, Farzaneh
    EUROPEAN JOURNAL OF TRANSLATIONAL MYOLOGY, 2022, 32 (04)
  • [44] Functional lung imaging in radiation therapy for lung cancer: A systematic review and meta-analysis
    Bucknell, Nicholas W.
    Hardcastle, Nicholas
    Bressel, Mathias
    Hofman, Michael S.
    Kron, Tomas
    Ball, David
    Siva, Shankar
    RADIOTHERAPY AND ONCOLOGY, 2018, 129 (02) : 196 - 208
  • [45] Ipilimumab-Based Therapy Consensus Statement From the Faculty of the Melanoma Nursing Initiative on Managing Adverse Events With Ipilimumab Monotherapy and Combination Therapy With Nivolumab
    Madden, Kathleen M.
    Hoffner, Brianna
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2017, 21 (04) : 30 - +
  • [46] Retrospective Analysis of Neutrophil-to-Lymphocyte Ratio in Patients with Melanoma Who Received Ipilimumab Monotherapy or Ipilimumab in Combination with Nivolumab in Japan
    Matsumura, Yuka
    Kawarada, Yuki
    Matsuo, Momo
    Yokota, Kenji
    Mizoguchi, Hiroyuki
    Akiyama, Masashi
    Yamada, Kiyofumi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2023, 46 (03) : 427 - 431
  • [47] Real-world efficacy of nivolumab plus ipilimumab combination therapy versus nivolumab monotherapy for Stage IV melanoma patients in Asia
    Takuya Maeda
    Azusa Hiura
    Jiro Uehara
    Rino Toyoshima
    Tomoe Nakagawa
    Koji Yoshino
    European Journal of Dermatology, 2021, 31 : 662 - 664
  • [48] Real-world efficacy of nivolumab plus ipilimumab combination therapy versus nivolumab monotherapy for Stage IV melanoma patients in Asia
    Maeda, Takuya
    Hiura, Azusa
    Uehara, Jiro
    Toyoshima, Rino
    Nakagawa, Tomoe
    Yoshino, Koji
    EUROPEAN JOURNAL OF DERMATOLOGY, 2021, 31 (05) : 662 - 664
  • [49] The efficacy and safety of combined immune checkpoint inhibitors (nivolumab plus ipilimumab): a systematic review and meta-analysis
    Jingjie Chen
    Shengnan Li
    Qigu Yao
    Nannan Du
    Xiaojun Fu
    Yuanmei Lou
    Mengru Wang
    Feiyan Mao
    Danyi Mao
    Parikshit Asutosh Khadaroo
    Yingying Tang
    World Journal of Surgical Oncology, 18
  • [50] Updated analysis of nivolumab and ipilimumab combination therapy in Japanese patients with advanced melanoma
    Takahashi, Akira
    Namikawa, Kenjiro
    Ogata, Dai
    Jinnai, Shunichi
    Nakano, Eiji
    Yamazaki, Naoya
    JOURNAL OF DERMATOLOGY, 2023, 50 (04): : 525 - 535
12345